Filed: 2/14/2023ACC: 0001420506-23-000696
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 88 equity positions with a total reported market value of $2.98B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
88
Positions
$2.98B
Total AUM (reported)
2.19B
Total Shares
Allocation by class
COM$1.45B48.4%
NOTE 11/1$156.74M5.3%
NOTE 2.625% 3/0$118.20M4.0%
NOTE 11/0$117.58M3.9%
COM NEW$110.24M3.7%
NOTE 0.375% 3/0$109.64M3.7%
NOTE 0.750% 8/0$103.14M3.5%
Portfolio Concentration
Top 3$392.52M13.2%
4–10$592.40M19.9%
11–25$780.10M26.1%
Rest$1.22B40.9%
Top 3 weight
13.2%
Top 10 weight
33.0%
Voting Authority Distribution
Total shares with voting rights: 2.19B
Sole
Full voting authority
2.19B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole88
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings88
Rows:
GUARDANT HEALTH INC
SOLEShares250.02M
TypePRN
Market value$156.74M
5.25%
Sole
250.02M
Shared
0.00
None
0.00
NANOSTRING TECHNOLOGIES INC
SOLEShares145.52M
TypePRN
Market value$118.20M
3.96%
Sole
145.52M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares131.83M
TypePRN
Market value$117.58M
3.94%
Sole
131.83M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares139M
TypePRN
Market value$109.64M
3.67%
Sole
139M
Shared
0.00
None
0.00
ALPHATEC HLDGS INC
SOLEShares112.25M
TypePRN
Market value$103.14M
3.46%
Sole
112.25M
Shared
0.00
None
0.00
NEVRO CORP
SOLEShares109.25M
TypePRN
Market value$100.24M
3.36%
Sole
109.25M
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares1.66M
TypeSH
Market value$72.59M
2.43%
Sole
1.66M
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares3.34M
TypeSH
Market value$71.54M
2.40%
Sole
3.34M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares252.54K
TypeSH
Market value$69.93M
2.34%
Sole
252.54K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.36M
TypeSH
Market value$65.32M
2.19%
Sole
1.36M
Shared
0.00
None
0.00
NATERA INC
SOLEShares1.62M
TypeSH
Market value$65.12M
2.18%
Sole
1.62M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares141.50M
TypePRN
Market value$63.67M
2.13%
Sole
141.50M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares3.47M
TypeSH
Market value$63.50M
2.13%
Sole
3.47M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.55M
TypeSH
Market value$61.04M
2.05%
Sole
1.55M
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares223.12K
TypeSH
Market value$59.20M
1.98%
Sole
223.12K
Shared
0.00
None
0.00
DECIPHERA PHARMACEUTICALS IN
SOLEShares3.27M
TypeSH
Market value$53.62M
1.80%
Sole
3.27M
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares65.98M
TypePRN
Market value$49.37M
1.65%
Sole
65.98M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares52.74M
TypePRN
Market value$48.95M
1.64%
Sole
52.74M
Shared
0.00
None
0.00
NEVRO CORP
SOLEShares1.19M
TypeSH
Market value$47.22M
1.58%
Sole
1.19M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares50.54M
TypePRN
Market value$46.65M
1.56%
Sole
50.54M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares497.67K
TypeSH
Market value$46.62M
1.56%
Sole
497.67K
Shared
0.00
None
0.00
ALIGN TECHNOLOGY INC
SOLEShares219.93K
TypeSH
Market value$46.38M
1.55%
Sole
219.93K
Shared
0.00
None
0.00
OUTSET MED INC
SOLEShares1.70M
TypeSH
Market value$44.01M
1.47%
Sole
1.70M
Shared
0.00
None
0.00
AMYRIS INC
SOLEShares137.85M
TypePRN
Market value$43.25M
1.45%
Sole
137.85M
Shared
0.00
None
0.00
ORTHOPEDIATRICS CORP
SOLEShares1.04M
TypeSH
Market value$41.51M
1.39%
Sole
1.04M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE 11/1 | 250.02M | PRN | $156.74M 5.25% | 250.02M | 0.00 | 0.00 |
NANOSTRING TECHNOLOGIES INCSOLE | NOTE 2.625% 3/0 | 145.52M | PRN | $118.20M 3.96% | 145.52M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE 11/0 | 131.83M | PRN | $117.58M 3.94% | 131.83M | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | NOTE 0.375% 3/0 | 139M | PRN | $109.64M 3.67% | 139M | 0.00 | 0.00 |
ALPHATEC HLDGS INCSOLE | NOTE 0.750% 8/0 | 112.25M | PRN | $103.14M 3.46% | 112.25M | 0.00 | 0.00 |
NEVRO CORPSOLE | NOTE 2.750% 4/0 | 109.25M | PRN | $100.24M 3.36% | 109.25M | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 1.66M | SH | $72.59M 2.43% | 1.66M | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 3.34M | SH | $71.54M 2.40% | 3.34M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 252.54K | SH | $69.93M 2.34% | 252.54K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.36M | SH | $65.32M 2.19% | 1.36M | 0.00 | 0.00 |
NATERA INCSOLE | COM | 1.62M | SH | $65.12M 2.18% | 1.62M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 141.50M | PRN | $63.67M 2.13% | 141.50M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 3.47M | SH | $63.50M 2.13% | 3.47M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.55M | SH | $61.04M 2.05% | 1.55M | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 223.12K | SH | $59.20M 1.98% | 223.12K | 0.00 | 0.00 |
DECIPHERA PHARMACEUTICALS INSOLE | COM | 3.27M | SH | $53.62M 1.80% | 3.27M | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | NOTE 3.000%10/1 | 65.98M | PRN | $49.37M 1.65% | 65.98M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | NOTE 4/0 | 52.74M | PRN | $48.95M 1.64% | 52.74M | 0.00 | 0.00 |
NEVRO CORPSOLE | COM | 1.19M | SH | $47.22M 1.58% | 1.19M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 50.54M | PRN | $46.65M 1.56% | 50.54M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 497.67K | SH | $46.62M 1.56% | 497.67K | 0.00 | 0.00 |
ALIGN TECHNOLOGY INCSOLE | COM | 219.93K | SH | $46.38M 1.55% | 219.93K | 0.00 | 0.00 |
OUTSET MED INCSOLE | COM | 1.70M | SH | $44.01M 1.47% | 1.70M | 0.00 | 0.00 |
AMYRIS INCSOLE | NOTE 1.500%11/1 | 137.85M | PRN | $43.25M 1.45% | 137.85M | 0.00 | 0.00 |
ORTHOPEDIATRICS CORPSOLE | COM | 1.04M | SH | $41.51M 1.39% | 1.04M | 0.00 | 0.00 |
Page 1 of 4